Holen Sie sich die Stockscreener-App
14.05
0.21%
0.03
Handel nachbörslich:
14.05
Schlusskurs vom Vortag:
$14.02
Offen:
$14
24-Stunden-Volumen:
281.95K
Relative Volume:
1.20
Marktkapitalisierung:
$731.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.43M
KGV:
-17.78
EPS:
-0.79
Netto-Cashflow:
$-39.97M
1W Leistung:
+1.52%
1M Leistung:
+4.54%
6M Leistung:
+49.63%
1J Leistung:
+65.88%
1-Tages-Spanne:
$13.71
$14.24
1-Wochen-Bereich:
$13.13
$14.42
52-Wochen-Spanne:
$6.00
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Vergleichen Sie GHRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
14.05 | 864.07M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Eingeleitet | Guggenheim | Buy |
| 2025-03-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-02-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-16 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Gh Research Plc Aktie (GHRS) Neueste Nachrichten
Can GH Research PLC outperform in the next rally2025 Technical Patterns & Fast Entry Momentum Trade Alerts - khodrobank.com
Can trapped investors hope for a rebound in GH Research PLC2025 Volatility Report & Reliable Trade Execution Plans - Newser
When is the best time to exit GH Research PLC2025 Analyst Calls & Real-Time Buy Zone Alerts - Newser
Heatmap analysis for GH Research PLC and competitorsWeekly Stock Analysis & Risk Managed Investment Strategies - Newser
Is GH Research PLC a candidate for recovery playJuly 2025 Decliners & Community Consensus Picks - Newser
Using Ichimoku Cloud for GH Research PLC technicalsWeekly Volume Report & Accurate Entry and Exit Point Alerts - Newser
Is GH Research PLC stock entering bullish territory2025 Investor Takeaways & Smart Money Movement Tracker - Newser
Trend analysis for GH Research PLC this weekQuarterly Portfolio Review & Technical Analysis for Trade Confirmation - Newser
Smart tools for monitoring GH Research PLC’s price action2025 EndofYear Setup & Safe Capital Investment Plans - Newser
How sentiment analysis helps forecast GH Research PLCJuly 2025 Final Week & AI Driven Stock Movement Reports - Newser
Multi factor analysis applied to GH Research PLCQuarterly Profit Review & Technical Pattern Based Signals - Newser
Volatility Watch: Does GH Research PLC have strong fundamentals2025 Bull vs Bear & Long-Term Capital Growth Strategies - khodrobank.com
What are GH Research PLC’s recent SEC filings showingCEO Change & Free Expert Verified Stock Movement Alerts - khodrobank.com
Real time social sentiment graph for GH Research PLCJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Will GH Research PLC bounce back from current support2025 Key Lessons & Smart Money Movement Tracker - Newser
Should you hold or exit GH Research PLC nowWeekly Investment Summary & High Accuracy Swing Trade Signals - Newser
Advanced analytics toolkit walkthrough for GH Research PLCInsider Selling & Accurate Buy Signal Alerts - Newser
What moving averages say about GH Research PLC2025 Performance Recap & Technical Pattern Alert System - Newser
What MACD and RSI say about GH Research PLC2025 Earnings Surprises & Long-Term Investment Growth Plans - Newser
How to build a dashboard for GH Research PLC stockQuarterly Growth Report & High Accuracy Buy Signal Tips - Newser
GH Research PLC's 73% Remission Rate in TRD and the Path to FDA Approval - AInvest
GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial - Yahoo Finance
Is GH Research PLC benefiting from interest rate changesJuly 2025 Closing Moves & Weekly High Conviction Trade Ideas - khodrobank.com
Using data filters to optimize entry into GH Research PLCMarket Weekly Review & Expert Curated Trade Ideas - Newser
Is GH Research PLC stock risky to hold nowTrade Performance Summary & Growth-Oriented Investment Plans - khodrobank.com
Will GH Research PLC benefit from government policyEarnings Beat & AI Forecasted Stock Moves - khodrobank.com
Will GH Research PLC outperform the marketJuly 2025 Movers & Real-Time Volume Analysis - Newser
Is GH Research PLC forming a bullish divergence2025 Price Momentum & Daily Oversold Bounce Ideas - theviewers.co.kr
GH Research PLC Rebound Backed by Sentiment Shift getLinesFromResByArray error: size == 0 - kangso.co.kr
Custom strategy builders for tracking GH Research PLCEarnings Trend Report & Expert Approved Momentum Ideas - Newser
GH Research PLC stock trend forecastMarket Movers & Proven Capital Preservation Methods - Newser
GH Research PLC to Engage Investors at Cantor Global Healthcare Conference - The Globe and Mail
Can GH Research PLC recover in the next quarterJuly 2025 Retail & Weekly High Return Stock Opportunities - Newser
How to interpret RSI for GH Research PLC stockWeekly Stock Report & Smart Swing Trading Techniques - Newser
Finanzdaten der Gh Research Plc-Aktie (GHRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):